BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current Knowledge
Schematic representation of the main pathways involved in melanoma cell resistance to targeted therapies
Publication
BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current Knowledge (2023)
Laetitia Florent, et al. Cancers (Basel). 2023 May;15(9). Figure: F3.
| Organism |
Group |
Word |
Match |
Source |
NCBI Symbol |
NCBI ID |
| Homo sapiens |
Primates |
HGF, |
HGF |
ncbigene_symbol |
HGF |
3082 |
| Homo sapiens |
Primates |
HGF, |
HGF |
ncbigene_synonym |
IL6 |
3569 |
| Homo sapiens |
Primates |
HGF, |
HGF |
ncbigene_synonym |
SOS1 |
6654 |
| Homo sapiens |
Primates |
TNFA, |
TNFA |
ncbigene_synonym |
TNF |
7124 |
| Homo sapiens |
Primates |
SFRP2 |
SFRP2 |
ncbigene_symbol |
SFRP2 |
6423 |
| Homo sapiens |
Primates |
TGFB |
TGFB |
ncbigene_synonym |
TGFB1 |
7040 |
| Homo sapiens |
Primates |
TGFB |
TGFB |
famplex_relations |
TGFB2 |
7042 |
| Homo sapiens |
Primates |
TGFB |
TGFB |
famplex_relations |
TGFB3 |
7043 |
| Homo sapiens |
Primates |
C-MET, |
C-MET |
ncbigene_synonym |
MET |
4233 |
| Homo sapiens |
Primates |
PDGFRB |
PDGFRB |
ncbigene_symbol |
PDGFRB |
5159 |
| Homo sapiens |
Primates |
Ras |
RAS |
famplex_relations |
KRAS |
3845 |
| Homo sapiens |
Primates |
Ras |
RAS |
famplex_relations |
HRAS |
3265 |
| Homo sapiens |
Primates |
Ras |
RAS |
famplex_relations |
NRAS |
4893 |
| Homo sapiens |
Primates |
NF1 |
NF1 |
ncbigene_symbol |
NF1 |
4763 |
| Homo sapiens |
Primates |
PTEN |
PTEN |
ncbigene_symbol |
PTEN |
5728 |
| Homo sapiens |
Primates |
PI3K |
PI3K |
ncbigene_synonym |
PIK3CA |
5290 |
| Homo sapiens |
Primates |
PI3K |
PI3K |
ncbigene_synonym |
PIK3CB |
5291 |
| Homo sapiens |
Primates |
PI3K |
PI3K |
ncbigene_synonym |
PIK3CD |
5293 |
| Homo sapiens |
Primates |
PI3K |
PI3K |
ncbigene_synonym |
PIK3CG |
5294 |
| Homo sapiens |
Primates |
PI3K |
PI3K |
famplex_relations |
PIK3R3 |
8503 |
| Homo sapiens |
Primates |
PI3K |
PI3K |
famplex_relations |
PIK3R4 |
30849 |
| Homo sapiens |
Primates |
PI3K |
PI3K |
famplex_relations |
PIK3R5 |
23533 |
| Homo sapiens |
Primates |
PI3K |
PI3K |
famplex_relations |
PIK3R6 |
146850 |
| Homo sapiens |
Primates |
PI3K |
PI3K |
famplex_relations |
PIK3R1 |
5295 |
| Homo sapiens |
Primates |
PI3K |
PI3K |
famplex_relations |
PIK3R2 |
5296 |
| Homo sapiens |
Primates |
Raf |
RAF |
ncbigene_synonym |
ZHX2 |
22882 |
| Homo sapiens |
Primates |
Raf |
RAF |
famplex_relations |
ARAF |
369 |
| Homo sapiens |
Primates |
Raf |
RAF |
famplex_relations |
BRAF |
673 |
| Homo sapiens |
Primates |
Raf |
RAF |
famplex_relations |
RAF1 |
5894 |
| Homo sapiens |
Primates |
MEK1/2) |
MEK1 |
ncbigene_synonym |
MAP2K1 |
5604 |
| Homo sapiens |
Primates |
elF3a |
EIF3A |
ncbigene_symbol |
EIF3A |
8661 |
| Homo sapiens |
Primates |
elF3a |
EIF3A |
ncbigene_synonym |
EIF6 |
3692 |
| Homo sapiens |
Primates |
elF3a |
EIF3A |
ncbigene_synonym |
EIF3J |
8669 |
| Homo sapiens |
Primates |
AKT |
AKT |
ncbigene_synonym |
AKT1 |
207 |
| Homo sapiens |
Primates |
AKT |
AKT |
famplex_relations |
AKT2 |
208 |
| Homo sapiens |
Primates |
AKT |
AKT |
famplex_relations |
AKT3 |
10000 |
| Homo sapiens |
Primates |
MEK |
MEK |
ncbigene_synonym |
MAP2K7 |
5609 |
| Homo sapiens |
Primates |
MEK |
MEK |
famplex_relations |
MAP2K2 |
5605 |
| Homo sapiens |
Primates |
mTOR |
MTOR |
ncbigene_symbol |
MTOR |
2475 |
| Homo sapiens |
Primates |
PPP2R1B |
PPP2R1B |
ncbigene_symbol |
PPP2R1B |
5519 |
| Homo sapiens |
Primates |
Erk1 |
ERK1 |
ncbigene_synonym |
MAPK3 |
5595 |
| Homo sapiens |
Primates |
Erk1/2 |
ERK2 |
ncbigene_synonym |
MAPK1 |
5594 |
| Homo sapiens |
Primates |
YAP |
YAP |
ncbigene_synonym |
YAP1 |
10413 |
| Homo sapiens |
Primates |
MITF |
MITF |
ncbigene_symbol |
MITF |
4286 |
| Homo sapiens |
Primates |
EDN1 |
EDN1 |
ncbigene_symbol |
EDN1 |
1906 |
| Word |
Match |
MeSH |
Name |
ChEBI |
| Ras |
RAS |
|
(1R)-N-(prop-2-yn-1-yl)indan-1-amine |
chebi:63620 |
| Vemurafenib |
vemurafenib |
|
N-(3-{[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide |
chebi:63637 |
| Dabrafenib |
dabrafenib |
|
N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide |
chebi:75045 |
| Cobimetinib |
cobimetinib |
|
bis[(2S)-2-{1-[3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzoyl]-3-hydroxyazetidin-3-yl}piperidin-1-ium] (2E)-but-2-enedioate |
chebi:90853 |
| Trametinib |
trametinib |
|
N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide |
chebi:75998 |
| Binimetinib |
binimetinib |
|
5-(4-bromo-2-fluoroanilino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide |
chebi:145371 |
| MEK |
MEK |
|
butan-2-one |
chebi:28398 |
Disease mentions
| Word |
Match |
MeSH |
Name |
DOID |